📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Glycostasis

1.1 - Company Overview

Glycostasis Logo

Glycostasis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of engineered human protein technology that releases insulin when blood glucose levels rise and binds it when levels fall, mimicking the natural regulation of insulin in healthy individuals.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Glycostasis

Biodel Logo

Biodel

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics for the treatment of diabetes, focused on developing and commercializing diabetes treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biodel company profile →
Biochemical Systems Logo

Biochemical Systems

HQ: Italy Website
  • Description: Provider of human and veterinary biochemistry analyzers, systems to measure glucose, cholesterol, and triglycerides, and accessories, serving laboratories, doctors offices, hospitals, and households.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biochemical Systems company profile →
CytoTools Logo

CytoTools

HQ: Germany Website
  • Description: Provider of unique biotechnology therapies derived from fundamental biology research on cell growth and programmed cell death, designed to treat the causes of disease rather than the symptoms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytoTools company profile →
GI Dynamics Logo

GI Dynamics

HQ: United States Website
  • Description: Provider of endoscopically delivered medical devices for managing type 2 diabetes, obesity, and related metabolic diseases, including RESET, which creates a barrier in the small intestine to improve insulin resistance and glycemic control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GI Dynamics company profile →
Bigfoot Biomedical Logo

Bigfoot Biomedical

HQ: United States Website
  • Description: Provider of diabetes management solutions for insulin-requiring individuals, offering the Bigfoot Unity system that integrates with the FreeStyle Libre 2 sensor to provide insulin dose recommendations for multiple-daily-injection users, the Bigfoot Unity Mobile App for dosing and glucose data, and the Bigfoot Clinic Hub for clinician data review; adheres to security and privacy laws, including HIPAA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bigfoot Biomedical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Glycostasis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Glycostasis

2.2 - Growth funds investing in similar companies to Glycostasis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Glycostasis

4.2 - Public trading comparable groups for Glycostasis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Glycostasis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Glycostasis

What does Glycostasis do?

Glycostasis is a provider of engineered human protein technology that releases insulin when blood glucose levels rise and binds it when levels fall, mimicking the natural regulation of insulin in healthy individuals.

Who are Glycostasis's competitors?

Glycostasis's competitors and similar companies include Biodel, Biochemical Systems, CytoTools, GI Dynamics, and Bigfoot Biomedical.

Where is Glycostasis headquartered?

Glycostasis is headquartered in United States.

How many employees does Glycostasis have?

Glycostasis has 1,000 employees 🔒.

When was Glycostasis founded?

Glycostasis was founded in 2010 🔒.

What sector and industry vertical is Glycostasis in?

Glycostasis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Glycostasis

Who are the top strategic acquirers in Glycostasis's sector and industry

Top strategic M&A buyers and acquirers in Glycostasis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Glycostasis?

Top strategic M&A buyers groups and sectors for Glycostasis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Glycostasis's sector and industry vertical

Which are the top PE firms investing in Glycostasis's sector and industry vertical?

Top PE firms investing in Glycostasis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Glycostasis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Glycostasis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Glycostasis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Glycostasis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Glycostasis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Glycostasis?

The key public trading comparables and valuation benchmarks for Glycostasis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Glycostasis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Glycostasis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Glycostasis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Glycostasis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Glycostasis's' sector and industry vertical?

Access recent funding rounds and capital raises in Glycostasis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Glycostasis